Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,641 | 189 | 98.5% |
| Consulting Fee | $25.00 | 1 | 0.9% |
| Education | $15.52 | 2 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $304.61 | 52 | $0 (2018) |
| GlaxoSmithKline, LLC. | $255.01 | 15 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $239.06 | 21 | $0 (2018) |
| Novo Nordisk Inc | $220.82 | 18 | $0 (2018) |
| Amgen Inc. | $179.48 | 7 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $176.02 | 10 | $0 (2018) |
| Takeda Pharmaceuticals America, Inc. | $169.75 | 9 | $0 (2017) |
| Lilly USA, LLC | $163.78 | 9 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $146.40 | 6 | $0 (2018) |
| Daiichi Sankyo Inc. | $119.63 | 6 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $25.00 | 1 | SANOFI PASTEUR INC. ($25.00) |
| 2018 | $372.26 | 20 | Amgen Inc. ($62.48) |
| 2017 | $2,285 | 171 | PFIZER INC. ($276.42) |
All Payment Transactions
192 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/25/2019 | SANOFI PASTEUR INC. | NO PRODUCT DISCUSSED (Drug) | Consulting Fee | In-kind items and services | $25.00 | General |
| 03/27/2018 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Vascepa | Food and Beverage | Cash or cash equivalent | $17.57 | General |
| Category: Cardiovascular | ||||||
| 03/26/2018 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Cardiovascular | ||||||
| 03/21/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.27 | General |
| 03/19/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/14/2018 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Endocrinology | ||||||
| 03/12/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/05/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/02/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $32.41 | General |
| Category: Cardiology | ||||||
| 03/01/2018 | Sanofi Pasteur Inc. | FLUZONE HIGH-DOSE (Drug) | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: VACCINES | ||||||
| 02/19/2018 | AbbVie, Inc. | Androgel (Drug), Synthroid | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Endocrinology | ||||||
| 02/16/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Central Nervous System (CNS) | ||||||
| 02/13/2018 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/09/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: UROLOGY | ||||||
| 02/06/2018 | PFIZER INC. | TOVIAZ (Drug), LYRICA | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: GENITOURINARY (UROLOGY) | ||||||
| 02/02/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $30.07 | General |
| Category: Cardiology | ||||||
| 01/23/2018 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Vascepa | Food and Beverage | Cash or cash equivalent | $15.66 | General |
| Category: Cardiovascular | ||||||
| 01/22/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/19/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Diabetes | ||||||
| 01/15/2018 | Sanofi Pasteur Inc. | FLUZONE HIGH-DOSE (Drug), ADACEL | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: VACCINES | ||||||
| 01/03/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/22/2017 | PFIZER INC. | VIAGRA (Drug), LYRICA | Food and Beverage | In-kind items and services | $9.48 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);CARDIOVASCULAR;RESPIRATORY | ||||||
| 12/22/2017 | PFIZER INC. | VIAGRA (Drug), LYRICA | Food and Beverage | In-kind items and services | $1.17 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);CARDIOVASCULAR;RESPIRATORY | ||||||
| 12/21/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Endocrinology | ||||||
| 12/19/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 627 | 803 | $290,127 | $36,145 |
| 2022 | 13 | 677 | 843 | $272,750 | $38,083 |
| 2021 | 12 | 691 | 877 | $270,122 | $58,476 |
| 2020 | 18 | 711 | 849 | $154,666 | $36,911 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 219 | 368 | $157,504 | $18,944 | 12.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 63 | 73 | $43,800 | $4,362 | 10.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 75 | 75 | $32,550 | $4,002 | 12.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 47 | 53 | $16,059 | $2,374 | 14.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 26 | 26 | $14,430 | $1,834 | 12.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $6,696 | $1,301 | 19.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 14 | 14 | $1,920 | $946.28 | 49.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 100 | 108 | $2,268 | $907.20 | 40.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 13 | 14 | $12,992 | $762.81 | 5.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 14 | $480.00 | $436.44 | 90.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 16 | 17 | $884.00 | $161.84 | 18.3% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 16 | 16 | $336.00 | $74.76 | 22.3% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 12 | 13 | $208.00 | $39.00 | 18.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 199 | 313 | $132,712 | $16,580 | 12.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 88 | 110 | $33,110 | $5,028 | 15.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 70 | 70 | $30,310 | $3,733 | 12.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $17,174 | $2,926 | 17.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 32 | 36 | $21,528 | $2,638 | 12.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 16 | 16 | $14,720 | $1,793 | 12.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 18 | 21 | $6,279 | $1,532 | 24.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 19 | 19 | $10,526 | $1,397 | 13.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 31 | 31 | $930.00 | $913.20 | 98.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 27 | 27 | $810.00 | $793.80 | 98.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 102 | 119 | $2,499 | $352.77 | 14.1% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 30 | 36 | $1,872 | $345.42 | 18.5% |
About Dr. Robert Eller, D.O
Dr. Robert Eller, D.O is a Internal Medicine healthcare provider based in West Linn, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770556201.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Eller, D.O has received a total of $2,682 in payments from pharmaceutical and medical device companies, with $25.00 received in 2019. These payments were reported across 192 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,641).
As a Medicare-enrolled provider, Eller has provided services to 2,706 Medicare beneficiaries, totaling 3,372 services with total Medicare billing of $169,615. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location West Linn, OR
- Active Since 02/07/2006
- Last Updated 12/20/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1770556201
Products in Payments
- VIAGRA (Drug) $220.26
- JANUVIA (Drug) $173.20
- BREO (Drug) $141.78
- TRADJENTA (Drug) $132.81
- Amitiza (Drug) $124.93
- Prolia (Biological) $117.00
- Saxenda (Drug) $113.82
- Victoza (Drug) $107.00
- INVOKANA (Drug) $91.53
- Movantik (Drug) $88.73
- XARELTO (Drug) $84.49
- Livalo (Drug) $82.14
- SYMBICORT (Drug) $77.90
- FARXIGA (Drug) $68.50
- Androgel (Drug) $65.74
- Repatha (Biological) $62.48
- FLUZONE HIGH-DOSE (Drug) $61.00
- Vascepa (Drug) $52.77
- ASMANEX (Drug) $52.49
- LYRICA (Drug) $45.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in West Linn
Jennifer Miller-Davis, Md, MD
Internal Medicine — Payments: $2,512
Dr. Huey Meeker, M.d, M.D
Internal Medicine — Payments: $442.94
Cristina De Castro-Dela Cruz, Md, MD
Internal Medicine — Payments: $22.90
Dr. Amy Gillcrist, Md, MD
Internal Medicine — Payments: $15.69
Colin Mcdonough, M.d, M.D
Internal Medicine
Dr. Gerald Melchor, M.d, M.D
Internal Medicine